Home | MyCME | All CME | Blog | Psychlopedia
All Expired CME Activities
Multimedia | CME From JCP | JCP Supplement | CME From PCC

MultimediaPronounced deficits in executive function are found in up to one-third of patients with MDD, and this impairment can keep patients from achieving full functional recovery. In this CME activity, review the evidence regarding the effectiveness of available interventions to improve cognitive dysfunction in patients with MDD. " [top]

Cognitive Impairment in Patients With Depression: Awareness, Assessment, and Management

Strategies for Managing Patients With Depression Who Are Experiencing Cognitive Impairment

Larry Culpepper, MD, MPH

Impact of Cognitive Impairment on Functioning in Patients With Depression

Raymond W. Lam, MD, FRCPC

Available Tools for Assessing Cognitive Impairment in Major Depressive Disorder

Roger S. McIntyre, MD, FRCPC

Emerging Treatment Strategies for Patients With Tardive Dyskinesia

Assessing Patients for Tardive Dyskinesia

John M. Kane, MD

Comparing Treatments for Tardive Dyskinesia

Leslie L. Citrome, MD, MPH

CME From JCPHow do treatments for posttraumatic stress disorder (PTSD) compare in routine clinical practice? Read this CME retrospective study of patient records for a look at real-life outcomes. Patients were taking fluoxetine, paroxetine, sertraline, topiramate, or venlafaxine, and some had concurrent psychotherapy. [top]

JCP CME Activities

A Retrospective Comparative Effectiveness Study of Medications for Posttraumatic Stress Disorder in Routine Practice

Brian Shiner, Christine Leonard Westgate, Jiang Gui, Shira Maguen, Yinong Young-Xu, Paula P. Schnurr, and Bradley V. Watts

An Examination of Screening Tools for Collaborative Care of Adolescent Depression

Alexander D. Ginsburg, Paul S. Stadem, Christopher R. Takala, Paul E. Croarkin, Angela B. Mattson, Marcie L. Billings, RoxAnne M. Brennan, and John E. Huxsahl

Emerging Treatment Strategies for Patients With Tardive Dyskinesia

Epidemiology, Prevention, and Assessment of Tardive Dyskinesia and Advances in Treatment

Christoph U. Correll, MD; John M. Kane, MD; and Leslie L. Citrome, MD, MPH

JCP SupplementAre you familiar with diagnostic criteria for Parkinson disease psychosis (PDP)? Do you know which psychotic symptoms occur in the majority of patients with PD? Read this CME supplement by 2 experts in the field for an update on PDP symptoms and treatments. [top]

Effective Management Approaches for Psychosis in Patients With Parkinson Disease

Effective Management Approaches for Psychosis in Patients With Parkinson Disease

Rajesh Pahwa, MD, and Daniel E. Kremens, MD, JD

CME From PCCWhat do you know about the use of synthetic marijuana among adolescents? Read this CME article to learn about why they use it, what the risks are, and whether they perceive it as dangerous. [top]

PCC CME Activities

Rates of Synthetic Cannabinoid Use in Adolescents Admitted to a Treatment Facility

Gloria Martz, William Tankersley, Hema Madhuri Mekala, and Huda Motiwala, MD

Obstructive Sleep Apnea in Posttraumatic Stress Disorder Comorbid With Mood Disorder: Significantly Higher Incidence Than in Either Diagnosis Alone

Bettina S. Fehr, William F. Katz, Erin A. Van Enkevort, and Imran S. Khawaja

​​